ESTRELLA IMMUNOPHARMA, INC. Shareholders' Equity
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Shareholders' Equity of -$7.43 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$7.43M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$5.27M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$10.37M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$9.84M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$7.43M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$5.27M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | -$10.37M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$9.84M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$6.09M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$1.83M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $143.73K 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $746.29K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $4.27M 10-K · filed 2026-03-18 | |
| 2024-03-31 | $8.49M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $9.05M 10-Q · filed 2025-11-12 | |
| 2023-09-30 | $10.07M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$11.74M 10-KT · filed 2025-03-25 | -$2.82M 10-Q · filed 2023-08-01 |
| 2023-03-31 | -$9.11M 10-Q · filed 2024-05-15 | -$2.53M 10-Q · filed 2023-05-18 |
| 2022-12-31 | -$6.48M 10-Q · filed 2024-05-15 | -$2.26M 10-K · filed 2023-03-14 |
| 2022-09-30 | -$3.82M 10-Q · filed 2024-05-15 | -$1.98M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$1.04M 10-K · filed 2024-09-27 | -$1.51M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$1.15M 10-Q · filed 2023-08-01 | |
| 2021-12-31 | -$1.01M 10-Q · filed 2023-08-01 | |
| 2021-09-30 | -$870.39K 10-Q · filed 2022-11-14 | |
| 2021-07-19 | -$612.35K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $20.63K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $24.18K 10-Q · filed 2022-11-14 | |
| 2021-01-05 | $0.00 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |